Threats to the value of Health Technology Assessment: Qualitative evidence from Canada and Poland

Health Technology Assessment is used to support the process of drug appraisal and reimbursement decisions in a variety of health systems. Examples can be found in mature Western countries, such as Canada, and in emerging economies of Central and Eastern Europe, such as Poland. The value of HTA in the process is influenced by the evidence used and the stakeholders involved.Qualitative interviews with 29 members of two appraisal committees were...